Co-Authors
This is a "connection" page, showing publications co-authored by Guiqiang Wang and Ke Wang.
Connection Strength
0.226
-
Tocilizumab combined with favipiravir in the treatment of COVID-19: A multicenter trial in a small sample size. Biomed Pharmacother. 2021 Jan; 133:110825.
Score: 0.226
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.